CRTR4

The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease

Impact of Age on Use of Neoadjuvant Chemoimmunotherapyand Outcomes for Patients with Triple‑Negative Breast Cancer